![Dan Hartman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dan Hartman
Direktor/Vorstandsmitglied bei
SPEXIS AG
Profil
Dan L.
Hartman is currently the Director-Integrated Development at the Bill & Melinda Gates Foundation Trust since 2012.
He is also currently serving as the Director at Spexis Ltd. since 2021.
Additionally, he holds the position of Director at EnBiotix, Inc. since 2012 and is a member of the Scientific and Medical Advisory Board at Hopen Life Sciences LLC.
Previously, Dr. Hartman held the position of President & Chief Executive Officer at Great Lakes Drug Development, Inc. from 2008 to 2012.
He also worked as an Executive Director & Principal at Pfizer Inc. from 2002 to 2005 and as a Principal at Eli Lilly & Co. from 1995 to 1999.
Furthermore, he served as the Vice President-Worldwide Clinical Development at Esperion Therapeutics, Inc. from 2000 to 2002 and as the Senior Vice President-Product Development at deCODE genetics, Inc. from 2005 to 2010.
Dr. Hartman's education includes a doctorate degree from Wayne State University (Michigan) and an undergraduate degree from Calvin University.
Aktive Positionen von Dan Hartman
| Unternehmen | Position | Beginn |
|---|---|---|
| SPEXIS AG | Direktor/Vorstandsmitglied | 30.12.2021 |
Gates Foundation Trust
 Gates Foundation Trust Financial ConglomeratesFinance Foundation | Corporate Officer/Principal | 01.01.2012 |
EnBiotix, Inc.
 EnBiotix, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Direktor/Vorstandsmitglied | - |
Hopen Life Sciences LLC
 Hopen Life Sciences LLC Investment ManagersFinance Hopen Life Sciences invests in companies located in the United States primarily in Midwest region. The firm focuses on sectors such as medical devices, diagnostics, therapeutics, healthcare and information technology. It participates in early to mid-stage capital requirements with an investment size of USD 3 - 5 million. | Berater | - |
Ehemalige bekannte Positionen von Dan Hartman
| Unternehmen | Position | Ende |
|---|---|---|
National Center for Advancing Translational Sciences
 National Center for Advancing Translational Sciences National AgencyGovernment National agency | Corporate Officer/Principal | 01.01.2019 |
Great Lakes Drug Development, Inc.
 Great Lakes Drug Development, Inc. Packaged SoftwareTechnology Services Develops software applications for drug development consultancy services | Vorstandsvorsitzender | 01.04.2012 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Corporate Officer/Principal | 01.02.2010 |
| PFIZER INC. | Direktor/Vorstandsmitglied | 01.01.2005 |
| ESPERION THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 |
Ausbildung von Dan Hartman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Health Technology |
Gates Foundation Trust
Gates Foundation Trust Financial ConglomeratesFinance Foundation | Finance |
Wayne State University (Michigan)
 Wayne State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calvin University
 Calvin University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
 Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
The American Society for Clinical Pharmacology & Therapeutics
 The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as scientific and professional organization serving the disciplines of clinical pharmacology and translational medicine | Commercial Services |
Hopen Life Sciences LLC
Hopen Life Sciences LLC Investment ManagersFinance Hopen Life Sciences invests in companies located in the United States primarily in Midwest region. The firm focuses on sectors such as medical devices, diagnostics, therapeutics, healthcare and information technology. It participates in early to mid-stage capital requirements with an investment size of USD 3 - 5 million. | Finance |
Great Lakes Drug Development, Inc.
Great Lakes Drug Development, Inc. Packaged SoftwareTechnology Services Develops software applications for drug development consultancy services | Technology Services |
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences National AgencyGovernment National agency | Government |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
